Review





Similar Products

antibodies against cd9  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc antibodies against cd9
Antibodies Against Cd9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+cd9/pm41910820-46-1-4
Average 86 stars, based on 1 article reviews
antibodies against cd9 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
antibodies against human cd9  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc antibodies against human cd9
Antibodies Against Human Cd9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+cd9/CD9+Rabbit+mAb/pm41860237-110-33-44
Average 96 stars, based on 1 article reviews
antibodies against human cd9 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
antibodies against cd9 cd81  (Servicebio Inc)
86
Servicebio Inc antibodies against cd9 cd81
Characterization of DPSCs and PDLSCs and uptake assay of DPSC-EXO. (A) The identification of surface markers of DPSCs and PDLSCs. (B) The expression of VNN2 and EXO-VNN2 in DPSCs was higher than that in PDLSCs and GMSCs. The overexpression of the VNN2 protein leads to an increase in its expression level in DPSCs. (C) Brightfield images of 3D- and 2D-cultured DPSCs. Scale bar = 200 μm. (D) TEM images showing the morphology of 2D- and 3D-EXOs. Scale bar = 100 nm. (E) Representative western blot image showing the expression of exosome markers <t>(CD9,</t> <t>CD81,</t> and TSG101) in 2D- and 3D-DPSC-EXOs. (F) Particle sizes and numbers of 2D- and 3D-EXOs were analyzed via NTA. (G) BCA assay determined the yields of 2D- and 3D-EXOs. (H) 2D- and 3D-DPSC-EXOs were endocytosed by PDLSCs. Data are presented as mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test. n = 3, * P < 0.05. ** P < 0.01. *** P < 0.001
Antibodies Against Cd9 Cd81, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+cd9/anti+cd81+cd9/pmc12973675-104-9-13
Average 86 stars, based on 1 article reviews
antibodies against cd9 cd81 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
antibodies against cd9  (Proteintech)
96
Proteintech antibodies against cd9
Characterization of DPSCs and PDLSCs and uptake assay of DPSC-EXO. (A) The identification of surface markers of DPSCs and PDLSCs. (B) The expression of VNN2 and EXO-VNN2 in DPSCs was higher than that in PDLSCs and GMSCs. The overexpression of the VNN2 protein leads to an increase in its expression level in DPSCs. (C) Brightfield images of 3D- and 2D-cultured DPSCs. Scale bar = 200 μm. (D) TEM images showing the morphology of 2D- and 3D-EXOs. Scale bar = 100 nm. (E) Representative western blot image showing the expression of exosome markers <t>(CD9,</t> <t>CD81,</t> and TSG101) in 2D- and 3D-DPSC-EXOs. (F) Particle sizes and numbers of 2D- and 3D-EXOs were analyzed via NTA. (G) BCA assay determined the yields of 2D- and 3D-EXOs. (H) 2D- and 3D-DPSC-EXOs were endocytosed by PDLSCs. Data are presented as mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test. n = 3, * P < 0.05. ** P < 0.01. *** P < 0.001
Antibodies Against Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+cd9/CD9+Antibody/pm41421228-74-9-12
Average 96 stars, based on 1 article reviews
antibodies against cd9 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
rabbit monoclonal antibodies against cd9  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc rabbit monoclonal antibodies against cd9
Characterization of DPSCs and PDLSCs and uptake assay of DPSC-EXO. (A) The identification of surface markers of DPSCs and PDLSCs. (B) The expression of VNN2 and EXO-VNN2 in DPSCs was higher than that in PDLSCs and GMSCs. The overexpression of the VNN2 protein leads to an increase in its expression level in DPSCs. (C) Brightfield images of 3D- and 2D-cultured DPSCs. Scale bar = 200 μm. (D) TEM images showing the morphology of 2D- and 3D-EXOs. Scale bar = 100 nm. (E) Representative western blot image showing the expression of exosome markers <t>(CD9,</t> <t>CD81,</t> and TSG101) in 2D- and 3D-DPSC-EXOs. (F) Particle sizes and numbers of 2D- and 3D-EXOs were analyzed via NTA. (G) BCA assay determined the yields of 2D- and 3D-EXOs. (H) 2D- and 3D-DPSC-EXOs were endocytosed by PDLSCs. Data are presented as mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test. n = 3, * P < 0.05. ** P < 0.01. *** P < 0.001
Rabbit Monoclonal Antibodies Against Cd9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+cd9/CD9+Rabbit+mAb/pm41373653-217-4-9
Average 96 stars, based on 1 article reviews
rabbit monoclonal antibodies against cd9 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Characterization of DPSCs and PDLSCs and uptake assay of DPSC-EXO. (A) The identification of surface markers of DPSCs and PDLSCs. (B) The expression of VNN2 and EXO-VNN2 in DPSCs was higher than that in PDLSCs and GMSCs. The overexpression of the VNN2 protein leads to an increase in its expression level in DPSCs. (C) Brightfield images of 3D- and 2D-cultured DPSCs. Scale bar = 200 μm. (D) TEM images showing the morphology of 2D- and 3D-EXOs. Scale bar = 100 nm. (E) Representative western blot image showing the expression of exosome markers (CD9, CD81, and TSG101) in 2D- and 3D-DPSC-EXOs. (F) Particle sizes and numbers of 2D- and 3D-EXOs were analyzed via NTA. (G) BCA assay determined the yields of 2D- and 3D-EXOs. (H) 2D- and 3D-DPSC-EXOs were endocytosed by PDLSCs. Data are presented as mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test. n = 3, * P < 0.05. ** P < 0.01. *** P < 0.001

Journal: Stem Cell Research & Therapy

Article Title: EXO-VNN2 derived from 3D-cultured DPSCs enhances the inflammatory response of PDLSCs and suppresses bone regeneration in periodontitis

doi: 10.1186/s13287-026-04922-9

Figure Lengend Snippet: Characterization of DPSCs and PDLSCs and uptake assay of DPSC-EXO. (A) The identification of surface markers of DPSCs and PDLSCs. (B) The expression of VNN2 and EXO-VNN2 in DPSCs was higher than that in PDLSCs and GMSCs. The overexpression of the VNN2 protein leads to an increase in its expression level in DPSCs. (C) Brightfield images of 3D- and 2D-cultured DPSCs. Scale bar = 200 μm. (D) TEM images showing the morphology of 2D- and 3D-EXOs. Scale bar = 100 nm. (E) Representative western blot image showing the expression of exosome markers (CD9, CD81, and TSG101) in 2D- and 3D-DPSC-EXOs. (F) Particle sizes and numbers of 2D- and 3D-EXOs were analyzed via NTA. (G) BCA assay determined the yields of 2D- and 3D-EXOs. (H) 2D- and 3D-DPSC-EXOs were endocytosed by PDLSCs. Data are presented as mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test. n = 3, * P < 0.05. ** P < 0.01. *** P < 0.001

Article Snippet: Western blotting was used to detect surface markers via antibodies against CD9/CD81 (1:500, Servicebio), TSG101, and calnexin.

Techniques: Expressing, Over Expression, Cell Culture, Western Blot, BIA-KA